A Multicentre, 12-Week Study of Imidapril and Candesartan Cilexetil in Patients with Mild to Moderate Hypertension Using Ambulatory Blood Pressure Monitoring

Author： Palma-Gamiz José L.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.27, Iss.6, 2007-01, pp. : 407-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil Assessed by 24-Hour Ambulatory Blood Pressure Monitoring in Patients with Essential Hypertension

By Brunner H.R.  

Clinical Drug Investigation, Vol. 23, Iss. 7, 2003-01 ,pp. : 419-430

Adis International

Access to resources Recommend Favorite

A 24-week Dose-titration Study of the Angiotensin-converting Enzyme Inhibitor Imidapril in the Treatment of Mild-to-moderate Essential Hypertension in the Elderly

By Dews I   VandenBurg M  

The Journal of International Medical Research, Vol. 29, Iss. 2, 2001-03 ,pp. : 100-107

Field House Publishing

Access to resources Recommend Favorite

Amlodipine Besylate versus Candesartan Cilexetil in Hypertensive Patients – Office and Self-Measured Blood Pressure: A Randomised, Double-Blind, Comparative, Multicentre Trial

By Trenkwalder P.  

Clinical Drug Investigation, Vol. 25, Iss. 9, 2005-01 ,pp. : 567-577

Adis International

Access to resources Recommend Favorite

Ambulatory Blood Pressure Comparison of the Anti-hypertensive Efficacy of Fixed Combinations of Irbesartan/hydrochlorothiazide and osartan/hydrochlorothiazide in Patients with Mild-to-moderate Hypertension

By Neutel JM   Smith D  

The Journal of International Medical Research, Vol. 33, Iss. 6, 2005-11 ,pp. : 620-631

Field House Publishing

Access to resources Recommend Favorite

Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil in Achieving 24-Hour Blood Pressure Reductions and Ambulatory Blood Pressure Goals

By Brunner Hans R.  

Clinical Drug Investigation, Vol. 26, Iss. 4, 2006-01 ,pp. : 185-193

Adis International

Access to resources Recommend Favorite